MREFX | VEURX | MREFX / VEURX | |
Total Expense Ratio | 1.40 | 0.25 | 560% |
Annual Report Gross Expense Ratio | 1.92 | 0.25 | 768% |
Fund Existence | 22 years | 35 years | - |
Gain YTD | 1.022 | 11.039 | 9% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 102M | 25.5B | 0% |
Annual Yield % from dividends | 1.53 | 3.01 | 51% |
Returns for 1 year | -3.79 | 5.38 | -70% |
Returns for 3 years | 14.53 | 12.48 | 116% |
Returns for 5 years | 91.69 | 72.11 | 127% |
Returns for 10 years | 35.55 | 31.04 | 115% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBDS | 24.18 | 0.08 | +0.33% |
iShares iBonds Dec 2027 Term Corp ETF | |||
EAOK | 25.57 | -0.17 | -0.64% |
iShares ESG Aware 30/70 Cnsrv Allc ETF | |||
DHF | 2.51 | -0.03 | -1.18% |
BNY Mellon High Yield Strategies Fund | |||
XJUL | 34.59 | -0.93 | -2.62% |
FT Vest U.S. Eq Enh & ModBufETF-Jul | |||
LABU | 53.61 | -5.82 | -9.79% |
Direxion Daily S&P Biotech Bull 3X ETF |